BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 11798060)

  • 1. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999.
    Evelyn B; Toigo T; Banks D; Pohl D; Gray K; Robins B; Ernat J
    J Natl Med Assoc; 2001 Dec; 93(12 Suppl):18S-24S. PubMed ID: 11798060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial/Ethnic composition of study participants in FDA-approved oncology new molecular entities, 2006-2008.
    Merenda C
    J Natl Med Assoc; 2012; 104(9-10):430-5. PubMed ID: 23342816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U.S. racial and ethnic participation in global clinical trials by therapeutic areas.
    Lolic M; Araojo R; Okeke M; Temple R
    J Clin Pharm Ther; 2021 Dec; 46(6):1576-1581. PubMed ID: 34544200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographics of clinical trials participants in pivotal clinical trials for new molecular entity drugs and biologics approved by FDA From 2010 to 2012.
    Eshera N; Itana H; Zhang L; Soon G; Fadiran EO
    Am J Ther; 2015; 22(6):435-55. PubMed ID: 25621972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Representation of Women and Minorities in Clinical Trials for New Molecular Entities and Original Therapeutic Biologics Approved by FDA CDER from 2013 to 2015.
    Chen A; Wright H; Itana H; Elahi M; Igun A; Soon G; Pariser AR; Fadiran EO
    J Womens Health (Larchmt); 2018 Apr; 27(4):418-429. PubMed ID: 29048983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
    Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond racial and ethnic analyses in clinical research: a proposed model for Institutional Review Boards.
    Eckstein L
    Food Drug Law J; 2011; 66(2):243-63, ii-iii. PubMed ID: 24505842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
    Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R
    Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of women in clinical trials for new drugs approved by the food and drug administration in 2000-2002.
    Yang Y; Carlin AS; Faustino PJ; Motta MI; Hamad ML; He R; Watanuki Y; Pinnow EE; Khan MA
    J Womens Health (Larchmt); 2009 Mar; 18(3):303-10. PubMed ID: 19243271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
    Allison K; Patel DG; Greene L
    JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.
    Downing NS; Shah ND; Neiman JH; Aminawung JA; Krumholz HM; Ross JS
    Trials; 2016 Apr; 17():199. PubMed ID: 27079511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
    Nooka AK; Behera M; Lonial S; Dixon MD; Ramalingam SS; Pentz RD
    Cancer; 2016 Oct; 122(20):3207-3214. PubMed ID: 27404488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrollment of racial/ethnic minorities and women with HIV in clinical research studies of HIV medicines.
    Sullivan PS; McNaghten AD; Begley E; Hutchinson A; Cargill VA
    J Natl Med Assoc; 2007 Mar; 99(3):242-50. PubMed ID: 17393948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in improving mental health services for racial-ethnic minority groups: a ten-year perspective.
    Santiago CD; Miranda J
    Psychiatr Serv; 2014 Feb; 65(2):180-5. PubMed ID: 24178249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial/ethnic differences in drug disposition and response: review of recently approved drugs.
    Ramamoorthy A; Pacanowski MA; Bull J; Zhang L
    Clin Pharmacol Ther; 2015 Mar; 97(3):263-73. PubMed ID: 25669658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of race or ethnicity on pharmacokinetics of drugs.
    Johnson JA
    J Pharm Sci; 1997 Dec; 86(12):1328-33. PubMed ID: 9423140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting, representation, and subgroup analysis of race and ethnicity in published clinical trials of atopic dermatitis in the United States between 2000 and 2009.
    Hirano SA; Murray SB; Harvey VM
    Pediatr Dermatol; 2012; 29(6):749-55. PubMed ID: 23017105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US.
    Priddy FH; Cheng AC; Salazar LF; Frew PM
    Int J STD AIDS; 2006 Feb; 17(2):99-102. PubMed ID: 16464270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.
    Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS
    Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race and Ethnicity in the Evidence for Integrating Palliative Care Into Oncology.
    Pirl WF; Saez-Flores E; Schlumbrecht M; Nipp R; Traeger LN; Kobetz E
    J Oncol Pract; 2018 Jun; 14(6):e346-e356. PubMed ID: 29813013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.